Metabolic pathway
SLU-PP-332
Single-component reagent
Laboratory verification
Nothing unverified is published
Every compound is prepared to a documented standard. Independent certificates of analysis are published here per batch as they are verified under Nuragen's own governance, we do not reuse another brand's certificates or purity figures.
Certificate of analysis · per batch · on request
Verification-led release
SLU-PP-332 is a single-component research reagent supplied for laboratory use only. It is a synthetic small molecule studied in the research literature as an agonist of the estrogen-related receptor (ERR) family within metabolic pathway investigations.
How it is studied
In the research literature, SLU-PP-332 is characterised as a synthetic agonist that binds and activates estrogen-related receptors (ERRs), a family of orphan nuclear receptors. Investigators have used it as a chemical tool to probe how ERR signalling influences the transcription of genes associated with mitochondrial function and energy metabolism. Because it is described as an exercise-mimetic in study contexts, it is examined for how it engages pathways that overlap with those activated during physical activity, purely as a mechanistic model in cell and preclinical systems.
What the components are and the pathway
This reagent contains a single defined component, SLU-PP-332, and no additional actives. It sits within the metabolic pathway category through its studied action on the ERR family, which acts as a transcriptional regulator of metabolic and mitochondrial gene programmes. Describing the compound this way keeps the focus on what it is and what it is thought to act on, rather than on any effect in a person or animal.
How it sits in a responsible research programme
SLU-PP-332 is provided as a single-component reagent so that researchers can attribute observations to one defined molecule and one primary pathway. This supports clean experimental design, reproducibility and clear documentation. It is intended to be handled by qualified personnel within an appropriate laboratory framework, alongside independent verification of identity and suitability for a given research question.
Composition
| Component | CAS | Purity |
|---|---|---|
| SLU-PP-332 | — | Pending |
| Type | Lyophilised powder |
|---|---|
| Presentation | Lyophilised powder |
| Appearance | White lyophilised powder |
| Storage | Store at 2-8°C, protected from light. |
| Dispatch | Delivered within 72 hours across the UK. |
Handling should follow standard laboratory practice and your own institutional protocols. No dosing, administration or medical guidance is provided.
SLU-PP-332 is a synthetic small-molecule reagent supplied strictly for research use only. In the research literature it is studied as an agonist of the estrogen-related receptor (ERR) family within metabolic pathway work. It is not a medicine, supplement or food, and it is not intended for human or animal use, diagnosis or any form of administration.
General laboratory practice for compounds of this type is storage at 2-8C and protection from light, with handling by trained personnel using appropriate protective equipment. Always follow the storage and handling guidance supplied with the material and your own institutional safety procedures, and confirm suitability for your specific protocol before use.
We provide a single-component research reagent and its accompanying documentation. We do not provide dosing information, protocols for administration, medical or veterinary advice, or any guidance on use in humans or animals, as these fall outside the research-use-only scope of the product.
That description comes from the research context, where the compound is used to engage ERR-linked metabolic and mitochondrial gene pathways that overlap with those active during physical activity. It reflects a mechanistic model studied in laboratory systems and describes what the molecule is thought to act on, not an effect that a person would experience.
In context
Evidence before action
SLU-PP-332 is best understood as a mechanistic tool: a way to interrogate ERR-linked metabolic signalling under controlled conditions. Reading the primary literature, noting the model systems used and distinguishing pathway activity from any real-world outcome all matter before any conclusion is drawn. Responsible research treats a compound as a question to be examined, not an answer to be assumed, and keeps interpretation anchored to what has actually been measured.
Related pathways
Explore alongside
Metabolic
Metabolic
MOTS-c, a mitochondrial-derived peptide studied in metabolic and fuel-use pathways. Research use only.
£150
Metabolic
RETA
Single-molecule triple-receptor agonist (GLP-1, GIP, glucagon) for metabolic-pathway research.
£150
Longevity
Cellular Energy
NAD+ coenzyme studied in cellular energy metabolism and repair pathways.
£150
Metabolic
Prime Cut
Multi-component proprietary blend studied in metabolic and growth-signalling research. Research use only.
£250